Duration of Hospitalization Clinical Trial
Official title:
Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project
Preliminary retrospective data suggest that the relatively soluble but inexpensive volatile
anesthesia isoflurane prolongs the duration of hospitalization compared to the less soluble
but more expensive anesthetic sevoflurane. Even a small reduction in the duration of
hospitalization would easily compensate for the modest additional cost of sevoflurane. The
investigators therefore propose to test the primary hypothesis that duration of
hospitalization is longer with isoflurane than sevoflurane.
The investigators will also test the secondary hypotheses that: 1) pain scores are greater
in patients recovering from isoflurane than sevoflurane anesthesia; and, 2) opioid
consumption is greater after isoflurane than sevoflurane anesthesia. All statistical
analyses will be adjusted for age, gender, race, baseline risk, 9 and procedure.
n/a
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05222113 -
OBSERVATIONAL STUDY OF COMPARISON EFFECTIVITY BETWEEN REMDESIVIR AND FAVIPIRAVIR IN SURABAYA, INDONESIA
|